Hearing on Third-Party Prescription Drug Programs
The House Oversight and Accountability Committee held a hearing on problems relating to pharmacy benefit managers (PBMs), which are companie… read more
The House Oversight and Accountability Committee held a hearing on problems relating to pharmacy benefit managers (PBMs), which are companies that negotiate drug costs with manufacturers on behalf of health insurers and other payers. Both Republican and Democratic representatives said that the three largest PBMs--CVS Caremark, Express Scripts, and Optum Rx--own 80% of the PBM market and alleged that such companies artificially inflate drug prices. The lawmakers also charged that these major PBMs have conflicts of interest in the pharmaceutical industry and are not transparent with their business deals. close
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.
You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.
People in this video
More PeopleHosting Organization
Featured Clips from This Video
-
Rep. Jamie Raskin Confirms His Cancer is in Remission
During a hearing of rising pharmacy costs, Maryland Democratic Representative Jamie Raskin confirms his cancer is in rem…
- 2 minutes
- 1,080 views
Related Video
-
National Drug Control Policy and the Overdose Crisis
Dr. Rahul Gupta, White House National Drug Control Policy director, said “for far too many years, the overdose crisis ha…
-
McKinsey and Company Executive and Others Testify on Opioid Epidemic
McKinsey and Company Global Managing Partner Bob Sternfels denied allegations by a congressional committee that the comp…
-
House Hearing on the Sackler Family and the Opioid Epidemic
The House Oversight and Reform Committee held a hearing on the Sackler family’s role in the U.S. opioid crisis. The Sack…
-
AbbVie Pharmaceutical CEO Testimony on Prescription Drug Pricing
Richard Gonzalez, CEO of AbbVie, testified before the House Oversight and Reform Committee on drug prices for two of the…